RxDoctor Payments Data

Robert Lentz, MD

Pulmonary Disease · Nashville, TNNPI 1003050972

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (35.1%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 72.7% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $7,883, 8.4 times the $933 reported in 2019.

$19,970in general payments, 2019–2025

Across 54 payments — averaging $369.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$15K
  • Medtronic$3K
  • Pulmonx Corporation$1K
  • ERBE USA Inc$314
  • Covidien LP$277
  • Noah Medical Corporation$270
  • plus $503 from 3 others

What the payments were for

  • Consulting fees$1,3507%
  • Speaking & faculty fees$6,35032%
  • Travel & lodging$2,19911%
  • Food & beverage$3,07115%
  • Education$7,00035%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,970 in reported general payments places this provider in the 85th percentile of 339 pulmonary disease providers in Tennessee.

See all pulmonary disease providers in Tennessee

Medicare billing

Part B allowed, 2024
$35,321
Medicare patients
120
Services billed
353

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole11$125

Paid to pharmacies, not to this prescriber.

Other pulmonary disease in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →